封面
市場調查報告書
商品編碼
1918202

病患定位系統市場 - 2026-2031年預測

Patient Positioning Systems Market - Forecast from 2026 to 2031

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 141 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計患者定位系統市場將維持 4.04% 的複合年成長率,從 2025 年的 16.59 億美元成長到 2031 年的 21.05 億美元。

受全球人口結構、疾病流行情況以及醫療服務技術進步等根本性變化的推動,患者體位擺放系統市場正經歷穩定成長。這些系統涵蓋手術台、體位輔助器具、坐墊和固定配件等多種設備,對於確保患者安全、提高手術精準度以及簡化外科和診斷操作流程至關重要。市場擴張是由多種相互關聯的因素共同驅動的,這些因素正在重塑臨床需求和投資重點。

推動該行業發展的主要且持續的因素是全球人口老化的趨勢。老年患者通常患有更多需要手術或診斷干預的慢性複雜疾病,導致需要精準定位的手術數量不斷增加。癌症在全球範圍內日益普遍,進一步加劇了這種人口壓力。對精準放射治療、用於診斷和分期的先進影像技術以及腫瘤外科手術的需求不斷成長,直接推動了對先進定位系統的需求,以確保在通常較為漫長的治療過程中,定位的可重複性、固定性和患者的舒適度。

同時,患者對醫療品質的意識和期望不斷提高,以及在診斷影像和微創手術方面的醫療費用支出不斷成長,正在推動市場成長。病患和醫療服務提供者都在尋求更安全、更有效率、更療效的醫療程序,而定位系統則透過預防神經損傷、壓瘡和不必要的組織暴露等併發症來實現這一目標。人們對微創技術的日益青睞,進一步凸顯了對專用手術台和配件的需求,這些設備能夠實現精準的解剖定位,並在精細的手術過程中穩定地固定患者。

技術創新是市場演進的關鍵前沿。將人工智慧 (AI) 和自動化技術整合到患者定位系統中,正成為一種變革性趨勢。基於 AI 的解決方案有望透過自動定位提高生產效率,透過整合 3D 相機系統實現一致的影像質量,並增強安全通訊協定以監測診斷成像環境中潛在的患者與機架碰撞。市場參與企業對這些智慧系統的開發和應用,正在創造新的成長機遇,並指引未來創新的方向。這正將定位從手動、靜態的過程轉變為手術流程中動態、數據驅動的組成部分。

在產品領域,手術台因其在外科手術和診斷應用中的核心作用而繼續佔據主導地位。精準高效的診斷影像日益重要,持續推動對能夠與CT、MRI和PET掃描儀等設備無縫整合的先進影像手術台的需求。同時,定位輔助設備市場也正經歷快速成長。這一細分市場的成長動力源於患者解剖結構的多樣性和手術操作要求的差異,因此需要各種專用墊、綁帶、真空袋和其他固定裝置,以確保在各個臨床專科中的安全性和精準性。

患者體位擺放系統的應用,尤其是在循環系統領域,已顯著成長。全球心血管疾病負擔日益加重,導致診斷和治療程序(包括心臟導管介入、電生理檢查和血管外科手術)的需求不斷增加。每項操作都需要特定的病患體位,以最佳化操作路徑、影像效果和手術成功率,從而推動了心臟監護病房和混合手術室對專用系統的應用。

從區域來看,北美預計將繼續保持主導地位,這得益於其先進的醫療基礎設施、創新醫療技術的高普及率以及包括癌症和心血管疾病在內的文明病相關慢性疾病的沉重負擔。該地區完善的法規結構和先進醫療設備的報銷機制也進一步推動了市場成長。歐洲預計也將佔據相當大的市場佔有率,這得益於其強大的醫療設備製造業、健全的醫療保健體係以及主要經濟體對臨床設施現代化建設的持續投資。

競爭格局的特點是注重創新和產品系列拓展的策略。主要市場參與企業正在開發和推出多樣化的產品,包括提升患者就醫便利性和舒適度的開放式系統,以及整合式人工智慧增強平台。他們正利用策略合作、地理擴張以及推出專為特定影像和手術應用而設計的新系統等商業策略,來鞏固市場地位並滿足不斷變化的臨床需求。其重點在於提供能夠改善手術流程、提升患者療效並為醫療機構創造價值的系統,以應對日益成長的手術量和複雜性。

本報告的主要優勢:

  • 深入分析:獲取主要和新興地區的深入市場洞察,重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局:了解全球主要企業的策略舉措,並了解透過正確的策略實現市場滲透的潛力。
  • 市場促進因素與未來趨勢:探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
  • 可操作的建議:利用這些見解,在動態環境中做出策略決策,並開拓新的商機和收入來源。
  • 受眾廣泛:適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業,且經濟實惠。

本報告的使用範例

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍:

  • 2021年至2025年的歷史數據和2026年至2031年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區分類的收入和預測評估,包括國家/地區
  • 公司概況(策略、產品、財務資訊)及主要發展動態

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 按產品分類的患者定位系統市場

  • 介紹
  • 桌子
  • 配件
  • 其他

6. 按應用分類的患者定位系統市場

  • 介紹
  • 外科手術
  • 疾病診斷
  • 癌症治療

7. 按最終用戶分類的患者定位系統市場

  • 介紹
  • 醫院和診所
  • 門診手術中心(ASC)
  • 診斷檢查室
  • 其他

8. 按地區分類的病患定位系統市場

  • 介紹
  • 北美洲
    • 依產品
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依產品
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 依產品
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 英國
      • 德國
      • 法國
      • 西班牙
      • 其他
  • 中東和非洲
    • 依產品
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 依產品
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 中國
      • 日本
      • 印度
      • 韓國
      • 台灣
      • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第10章:公司簡介

  • Stryker
  • Integra LifeSciences
  • Globus Medical
  • Qfix
  • Xodus Medical
  • Ergotrics
  • Cemar Electro

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061616034

Patient Positioning Systems Market, sustaining a 4.04% CAGR, is projected to expand from USD 1.659 billion in 2025 to USD 2.105 billion in 2031.

The patient positioning systems market is experiencing steady growth, propelled by fundamental shifts in global demographics, disease prevalence, and technological innovation within healthcare delivery. These systems, which encompass a range of devices including procedure tables, positioning aids, cushions, and immobilization accessories, are critical for ensuring patient safety, procedural precision, and operational efficiency across surgical and diagnostic settings. The market's expansion is underpinned by several interrelated factors that are reshaping clinical requirements and investment priorities.

A primary and enduring driver for the industry is the demographic trend of an aging global population. Older patients typically present with a higher incidence of chronic and complex conditions requiring surgical or diagnostic intervention, thereby increasing the volume of procedures where precise positioning is paramount. This demographic pressure is compounded by the rising prevalence of cancer worldwide. The increasing need for accurate radiation therapy, advanced imaging for diagnosis and staging, and surgical oncology procedures directly fuels demand for sophisticated positioning systems that ensure reproducibility, immobilization, and patient comfort during often prolonged treatments.

Concurrently, rising patient awareness and expectations regarding care quality, coupled with increased healthcare expenditure on diagnostic imaging and minimally invasive surgeries, are driving market growth. Patients and providers alike seek safer, more efficient procedures with improved outcomes, which positioning systems facilitate by preventing complications such as nerve damage, pressure ulcers, and unnecessary tissue exposure. The growing preference for minimally invasive techniques further accentuates the need for specialized tables and accessories that enable precise anatomical access and stable patient immobilization throughout delicate operations.

Technological advancement represents a significant frontier for market evolution. The integration of Artificial Intelligence (AI) and automation into patient positioning systems is emerging as a transformative trend. AI-based solutions offer the potential for enhanced productivity through automated positioning, consistent imaging quality via integrated 3D camera systems, and improved patient safety protocols, including monitoring for potential patient-gantry collisions in imaging environments. The development and introduction of these intelligent systems by market participants are creating new growth opportunities and setting a trajectory for future innovation, moving positioning from a manual, static process to a dynamic, data-driven component of the procedural workflow.

Within the product landscape, procedure tables continue to hold a dominant position due to their central role in both surgical and diagnostic applications. The critical need for accurate and efficient diagnostic imaging sustains demand for advanced imaging tables that integrate seamlessly with modalities like CT, MRI, and PET scanners. Simultaneously, the market for positioning accessories is experiencing rapid growth. This segment is driven by the diversity of patient anatomies and procedural requirements, necessitating a wide array of specialized cushions, straps, vacuum bags, and other immobilization devices to ensure safety and precision across different clinical specialties.

The application of patient positioning systems in cardiology is notably increasing. The high and growing global burden of cardiovascular diseases necessitates a rising volume of diagnostic and interventional procedures, such as cardiac catheterizations, electrophysiology studies, and vascular surgeries. Each of these requires specific patient positioning to optimize access, imaging, and procedural success, thereby driving adoption of specialized systems within cardiac care units and hybrid operating rooms.

Geographically, North America is projected to maintain leadership in the patient positioning systems market. This can be attributed to its advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and a significant burden of lifestyle-related chronic illnesses, including cancer and cardiovascular disease. The region's well-established regulatory framework and reimbursement pathways for advanced medical devices further support market growth. Europe is also anticipated to hold a substantial market share, supported by a robust medical device manufacturing sector, strong healthcare systems, and ongoing investment in modernizing clinical facilities across major economies.

The competitive landscape is characterized by strategies focused on innovation and portfolio expansion. Key market participants are engaged in developing and launching diversified product offerings, including open-configuration systems for enhanced patient accessibility and comfort, as well as integrated, AI-enhanced platforms. Business strategies such as strategic collaborations, regional expansion, and the introduction of novel systems designed for specific imaging or surgical applications are being employed to strengthen market presence and address evolving clinical needs. The focus remains on delivering systems that improve procedural workflow, enhance patient outcomes, and provide value to healthcare institutions navigating increasing procedural volumes and complexity.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Segmentation:

  • By Product
  • Tables
  • Accessories
  • Others
  • By Application
  • Surgery
  • Disease Diagnosis
  • Cancer Therapy
  • By End-User
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Others
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PATIENT POSITIONING SYSTEMS MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Tables
  • 5.3. Accessories
  • 5.4. Others

6. PATIENT POSITIONING SYSTEMS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Surgery
  • 6.3. Disease Diagnosis
  • 6.4. Cancer Therapy

7. PATIENT POSITIONING SYSTEMS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Ambulatory Surgical Centers (ASCs)
  • 7.4. Diagnostic Laboratories
  • 7.5. Others

8. PATIENT POSITIONING SYSTEMS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Drug Class
    • 8.2.2. By Indication
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Drug Class
    • 8.3.2. By Indication
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Drug Class
    • 8.4.2. By Indication
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Drug Class
    • 8.5.2. By Indication
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Drug Class
    • 8.6.2. By Indication
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Stryker
  • 10.2. Integra LifeSciences
  • 10.3. Globus Medical
  • 10.4. Qfix
  • 10.5. Xodus Medical
  • 10.6. Ergotrics
  • 10.7. Cemar Electro

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations